Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

Children with rheumatic diseases may face increased risks for COVID-19-related hospitalization, particularly those using glucocorticoids, rituximab, or mycophenolate.

ACUTE rheumatic fever, in the absence of intercurrent streptococcal respiratory infections and rheumatic recrudescences, is generally a self-limited disease that subsides within twelve weeks.

Rheumatic heart disease is a chronic condition that results years after acute rheumatic fever, which is caused by group A beta-hemolytic Streptococcus pyogenes. This organism produces a ...

The following is a summary of “Development of START, a novel multimedia-based symptom appraisal tool for autoimmune rheumatic ...

Rheumatic heart disease (RHD) constitutes a leading cause of premature death and incapacity in Africa, where it is encountered in younger people, and shows a much faster and more serious course ...

A RECENT review of the literature 1 and our own experience at the House of the Good Samaritan 2–5 suggest that early treatment of rheumatic fever with ACTH and cortisone may prevent or mitigate ...

The historical record shows that the battle to prevent and find cures for infectious disease will lead to a lower incidence ...

The research of the Helsinki Rheumatic diseases and Inflammation Group focuses on studying the mechanisms of inflammation in rheumatic diseases and osteoarthritis, with special emphasis on role of ...